STOCK TITAN
  1. Home
  2. Sec-filings
  3. HNGE
  4. [144] Hinge Health, Inc. SEC Filing

Hinge Health 10% holder plans $754K share sale

The Rule 144 notice outlines planned sales of 8,382 Class A shares worth about $754,380, plus a later in-kind distribution of 33,528 shares.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) received a Rule 144 notice from JL 2025 Family Trust LLC, a 10% stockholder, covering planned sales of Class A common stock. The filing lists 8,382 Class A shares with an aggregate market value of $754,380.00, with 62,468,721 Class A shares outstanding as of 09/01/2026. It also discloses an in-kind distribution of 33,528 Class A shares dated 08/10/2026 from various Insight entities. The notice further details extensive Class A share sales in June–August 2026 by multiple Insight Venture Partners funds and an individual associated with those entities.

Positive

  • None.

Negative

  • None.
Class A shares in primary Rule 144 line 8,382 shares Class A securities line with Raymond James & Associates, Inc.
Aggregate market value of securities $754,380.00 Aggregate market value associated with 8,382 Class A shares
Class A shares outstanding 62,468,721 shares Class A shares outstanding as of 09/01/2026
In-kind distribution of Class A shares 33,528 shares In-kind distribution dated 08/10/2026 from various Insight entities
Example prior sale by Insight Venture Partners (Cayman) X, L.P. 600,613 shares for $49,750,937.00 Class A sale on 06/29/2026
Example prior sale by Insight Venture Partners X, L.P. 732,444 shares for $60,670,973.32 Class A sale on 06/29/2026
Example individual sale by Thomas M. Triplett 66,967 shares for $6,027,030.00 Class A sale on 08/10/2026
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
In-Kind Distribution financial
"Class A | 08/10/2026 | In-Kind Distribution from various Insight entities"
A distribution of value to shareholders or beneficiaries made by transferring assets instead of paying cash, such as shares, bonds, or property. Like receiving a box of goods rather than money, it changes what you hold rather than adding liquid funds; investors care because it affects a portfolio’s composition, liquidity, tax reporting, and cost basis for the received assets.
10% Stockholder financial
"10% Stockholder 144: Securities Information"
attorney-in-fact regulatory
"as attorney-in-fact for JL 2025 Family Trust LLC"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
aggregate market value financial
"| 8382 | 754380.00 | 62468721 | 09/01/2026 | NYSE"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing mean for HNGE (Hinge Health, Inc.)?
The filing reports that JL 2025 Family Trust LLC, a 10% stockholder, intends to sell and distribute certain Class A shares of Hinge Health, Inc. under Rule 144. It is a notice of proposed sales and recent sales by related Insight Venture Partners entities.

How many HNGE shares are covered by the primary Rule 144 notice?
The notice lists 8,382 Class A shares of Hinge Health, Inc. with an aggregate market value of $754,380.00. These figures are tied to the planned Rule 144 sales referenced in the filing for JL 2025 Family Trust LLC, using Raymond James & Associates, Inc. as broker.

What in-kind distribution of HNGE shares is disclosed in the Form 144?
An in-kind distribution dated 08/10/2026 is reported for 33,528 Class A shares of Hinge Health, Inc. from various Insight entities, associated with JL 2025 Family Trust LLC and Insight Venture Partners.

How many HNGE shares were outstanding as of 09/01/2026?
The filing states that 62,468,721 Class A shares of Hinge Health, Inc. were outstanding as of 09/01/2026. This serves as a baseline figure for assessing the relative size of the planned and recent Rule 144 sales.

Which broker is handling the Rule 144 sales for JL 2025 Family Trust LLC in HNGE?
The Rule 144 notice identifies Raymond James & Associates, Inc. as the broker, with its office in St. Petersburg, Florida, handling transactions in Class A shares of Hinge Health, Inc. for JL 2025 Family Trust LLC.

What prior HNGE share sales by Insight Venture Partners funds are disclosed?
The filing lists multiple prior sales of Class A shares in June–August 2026 by Insight Venture Partners funds. Examples include 600,613 shares sold on 06/29/2026 for $49,750,937.00 and 732,444 shares sold the same date for $60,670,973.32.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR